Abstract:Natural bisindole alkaloids such as Hyrtinadine A and Alocasin A, which are known to exhibit diverse bioactivities, provide promising chemical scaffolds for drug development. By optimizing the Masuda borylation–Suzuki coupling sequence, a library of various natural product-derived and non-natural (di)azine-bridged bisindoles was created. While unsubstituted bisindoles were devoid of antibacterial activity, 5,5′-chloro derivatives were highly active against methicillin-resistant Staphylococcus aureus (MRSA) and further Gram-positive pathogens at minimal inhibitory concentrations ranging from 0.20 to 0.78 μM. These compounds showed strong bactericidal killing effects but only moderate cytotoxicity against human cell lines. Furthermore, the two front-runner compounds 4j and 4n exhibited potent in vivo efficacy against MRSA in a mouse wound infection model. Although structurally related bisindoles were reported to specifically target pyruvate kinase in MRSA, antibacterial activity of 4j and 4n is independent of pyruvate kinase. Rather, these compounds lead to bacterial membrane permeabilization and cellular efflux of low-molecular-weight molecules.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00826?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00826</a>.MICs of compounds 4 against all tested bacteria strains (Table S1); cytotoxicity data of compounds 4j, 4n, and 4q against the human cell lines HEK293, HepG2, and CLS-54 (Table S2); SNPs present in MRSA resistant mutants (Table S3); MICs of compounds of different classes against MRSA resistant mutants and wild-type (Table S4); dose–response curve of compound 4r against MRSA (Figure S1); solubility assessment of compounds 4c, 4d, 4j, 4n, and 4r (Figure S2); absorption maxima of compounds 4c, 4d, 4j, 4n, and 4r (Figure S3); hemolytic activity of 4j and 4n on sheep red blood cells (Figure S4); stability evaluation of compound 4c (Figure S5); dose–response curves for 4d, 4n, 4q, and 4s against MRSA LAC WT and LAC Δpyk::ErmR in minimal medium M9 (Figure S6); studies describing optimization of reaction conditions (Scheme S1 and Table S5); analytical data of compounds 1a, 4a–4f, 4j, 4l–4n, 4p–4s, 4u, and 4v including 1H and 13C NMR spectra (Figures S7–S40) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Design, Synthesis, and Biological Evaluation of Novel Pyrimido[4,5- b ]indole Derivatives Against Gram-Negative Multidrug-Resistant Pathogens

Discovery of Natural Berberine-Derived Nitroimidazoles As Potentially Multi-Targeting Agents Against Drug-Resistant Escherichia Coli

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection

Optimized Arylomycins Are a New Class of Gram-negative Antibiotics.

Optimization Of Globomycin Analogs As Novel Gram-Negative Antibiotics

Design, synthesis, and evaluation of novel pleuromutilin aryl acrylate derivatives as promising broad-spectrum antibiotics especially for combatting multi-drug resistant gram-negative bacteria

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Design, synthesis, and bioactivity investigation of novel cyclic lipopeptide antibiotics targeting top-priority multidrug-resistant gram-negative bacteria

Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria

Design, synthesis and evaluation of novel LpxC inhibitors containing a hydrazone moiety as Gram-negative antibacterial agents

A Novel Chemical Biology and Computational Approach to Expedite the Discovery of New-Generation Polymyxins Against Life-Threatening Acinetobacter Baumannii

Development of Bis-cyclic Imidazolidine-4-one Derivatives as Potent Antibacterial Agents

Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance

Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine

The Anti-Multidrug-Resistant Acinetobacter Baumannii Study on 1,3-Diamino-7h-pyrrolo[3,2-f]quinazoline Compounds

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-oxazolidinone Derivatives As Antibacterial Agents.

Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial In Vitro and In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus

Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-pyridone Type II DNA Topoisomerase Inhibitors Active Against Multidrug Resistant Gram-negative Bacteria

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell

Design, Synthesis and Biological Evaluation of Novel Tetrahydroisoquinoline Derivatives As P-glycoprotein-mediated Multidrug Resistance Inhibitors.

Design, Synthesis and Biological Evaluation of LBM-A5 Derivatives As Potent P-glycoprotein-mediated Multidrug Resistance Inhibitors.